欧洲议会投票通过决议，推动解决大麻准入障碍

摘要：欧洲议会2月13日通过决议，促进欧盟成员国对医用大麻的研究和获取。表明欧洲议会决心帮助其成员国制定国际范围的大麻法规和研究模式，实现大麻获取机会平等，以及与WHO合作。 #大麻#

The European Parliament voted February 13 on a resolution that would help promote research on and access to medical marijuana in the countries that form the European Union.

欧洲议会于2月13日投票通过了一项决议，该决议将有助于促进欧盟成员国对医用大麻的研究和获取。

While the resolution is a non-binding legal document, it does, in conjunction with the World Health Organization’s recommendation to reschedule marijuana, show that pot is a popular political topic on the international stage.

尽管该决议是一份不具约束力的法律文件，但它与世界卫生组织关于重新安排大麻使用期限的建议一起表明，大麻是国际舞台上流行的政治议题。

The resolution calls on European nations to increase access to medical marijuana for specific illnesses and places a prioritization on scientific research and clinical studies.

该决议呼吁欧洲国家增加特定疾病使用医用大麻的机会，并优先重视科学研究和临床研究。

“The EU Parliament is just the latest voice to recognize the medical value of cannabis and the benefits of regulation over prohibition,” Tom Angell, publisher of Marijuana Moment, said in an interview. “I’m hopeful that the growing chorus in favor of reform will spur action by nations to change their policies and improve access for patients who need this medicine.”

“欧盟议会只是认识到大麻的医疗价值和监管对禁止的好处的最新声音，” Marijuana Moment 的出版商汤姆·安赫尔( Tom Angell )在一次采访中说。“我希望，支持改革的呼声越来越高，这将促使各国采取行动，改变政策，改善需要这种药物的患者的就诊渠道。” $Canopy Growth Corporation(CGC)$ $Tilray Inc.(TLRY)$